Test Manager aims to enhance productivity, collaboration, and efficiency in test management by providing a centralized,…
Continue ReadingCategoría: Business Wire
Categoría agregada por el Plugin WPeMatico
Septerna Presents Preclinical Data at ENDO 2024 Highlighting Therapeutic Potential of its GPCR Drug Discovery Platform
Oral, small molecule parathyroid hormone 1 receptor (PTH1R) agonist maintained serum calcium control over 28-day dosing…
Continue Reading
American Lending Center Celebrates 15 Years Of Growth
IRVINE, Calif.–(BUSINESS WIRE)–American Lending Center, a private non-bank lending institution nationally recognized for both small business…
Continue Reading
OKI Signs Partnership Agreement with US-based Plug and Play
–Commencing global open innovation activities based in Silicon Valley– TOKYO–(BUSINESS WIRE)–OKI (TOKYO: 6703) has signed an…
Continue Reading
TAGRISSO® (osimertinib) reduced the risk of disease progression or death by 84% in patients with unresectable, Stage III EGFR-mutated lung cancer vs. placebo in LAURA Phase III trial
First and only EGFR inhibitor and targeted treatment to show benefit in Stage III setting, extending…
Continue Reading
CatalYm Reports Impressive and Lasting Responses Including Multiple Complete Responses in Heavily Pretreated, Late- to Last-Line Metastatic NSCLC, Urothelial and Hepatocellular Cancer Patients Treated with Visugromab/Nivolumab Combination
The results include data from three main study cohorts: In the non-squamous non-small cell lung cancer…
Continue Reading
Stronger Than Ever: Adani Portfolio Delivers Record Performance
45% EBITDA growth in FY24, EBITDA reaches USD 10 Bn Adani Portfolio EBITDA increased to USD…
Continue Reading
Belantamab Mafodotin combination reduced the risk of disease progression or death by nearly 50% versus standard of care combination in relapsed/refractory multiple myeloma
DREAMM-8 phase III trial showed statistically significant and clinically meaningful improvement in primary endpoint of progression-free…
Continue Reading
Denodo Opens ME Regional Head Office in Kingdom of Saudi Arabia to Meet Growing Demand for Data Management and AI
At the office opening today, Ángel Viña, CEO of Denodo will be joined by Dr. Shaikha…
Continue Reading
IMFINZI® (durvalumab) is the first and only immunotherapy to show survival benefit in limited-stage small cell lung cancer in global Phase III trial, reducing the risk of death by 27% vs. placebo
57% of patients treated with IMFINZI were alive at three years in ADRIATIC Phase III trial…
Continue Reading